Arthrex ACP® 

 The Next Generation PRP

100% Autologous, Pain-Free, and FDA-Approved

Arthrex ACP® (Autologous Conditioned Plasma) is a next-generation PRP system engineered to deliver high-quality platelet-rich plasma with a consistent and validated concentration of growth factors—without the use of anticoagulants. Designed as a closed, sterile system, Arthrex ACP® ensures safety, reproducibility, and superior clinical outcomes across regenerative and aesthetic applications.

This FDA-approved PRP technology produces plasma with uniform platelet distribution, allowing a gradual and sustained release of growth factors that supports tissue regeneration, collagen synthesis, and long-term healing—often with fewer sessions than conventional PRP systems.

Key Benefits & Features

· Minimally painful PRP procedure with no anticoagulant

· Delivers a higher concentration of platelets and growth factors

· Enables gradual, sustained growth factor release for longer-lasting results

· Promotes tissue regeneration, collagen production, and wound healing

· Requires fewer treatment sessions compared to conventional PRP

· FDA-approved, sterile, and contamination-free system

· Closed PRP system – maintains sterility from blood extraction to injection

· High yield output – 6–6.5 ml plasma (≈30% more than conventional PRP tubes)

· Validated platelet concentration – approximately 2.5× fold enrichment

· Even platelet distribution – no PPP, no buffy coat, uniform growth factor delivery

· Demonstrates superior histological, regenerative, and aesthetic outcomes

 

Clinical Indications

· Facial rejuvenation (nasolabial folds, crow’s feet, periorbital region)

· Hair restoration therapy – Androgenetic Alopecia – Alopecia Areata – Alopecia Barbae

· Hand and foot rejuvenation

· Wound healing and non-healing ulcers

· Scar treatment and dermal augmentation

· Stretch marks (striae)

 

Recommended Protocol

· 3 sessions of ACP-PRP, spaced 1 month apart, for optimal regenerative and aesthetic outcomes

· Protocol may be individualized based on clinical indication and physician discretion

SAFETY

Certified as a medical device, the Arthrex ACP double syringe offers a closed, sterile, needle-free system for use in the practice or operating theater.

MADE IN GERMANY

  • The Arthrex ACP double syringe is manufactured in Germany.
  • A quality management system in accordance with DIN ISO 13485 is in place for quality assurance.

EFFICIENT AND QUICK

  • 15 ml of whole blood yields approximately 5-6 ml of PRP.
  • The whole process takes 20 mins.